Evidence map›Paper›PMID 31217330›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Strengthening of the Efferent Olivocochlear System Leads to Synaptic Dysfunction and Tonotopy Disruption of a Central Auditory Nucleus.

Mariano N Di Guilmi, Luis E Boero, Valeria C Castagna, Adrián Rodríguez-Contreras, Carolina Wedemeyer, María Eugenia Gómez-Casati, Ana Belén Elgoyhen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Co-release of GABA and ACh from Medial Olivocochlear Neurons as a Fine Regulatory Mechanism of Cochlear Efferent Inhibition.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  3. Article
  4. Strengthening Medial Olivocochlear Feedback Reduces the Developmental Impact of Early Noise Exposure.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Genetic tools for studying cochlear inhibition.Frontiers in cellular neuroscience · 2024
    Review
  11. Engineering olivocochlear inhibition to reduce acoustic trauma.Molecular therapy. Methods & clinical development · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Purinergic Signaling Controls Spontaneous Activity in the Auditory System throughout Early Development.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mariano N Di GuilmiInstituto de Investigaciones en Ingeniería Genética y Biología Molecular, Dr. Héctor N. Torres, INGEBI-CONICET, Buenos Aires, Argentina C1428ADN, elgoyhen@dna.uba.ar abelgoyhen@gmail.com mndiguilmi@dna.uba.ar.ORCID 0000-0002-3918-296X
Luis E BoeroInstituto de Investigaciones en Ingeniería Genética y Biología Molecular, Dr. Héctor N. Torres, INGEBI-CONICET, Buenos Aires, Argentina C1428ADN.ORCID 0000-0003-1758-616X
Valeria C CastagnaInstituto de Farmacología, Facultad de Medicina, UBA, Buenos Aires, Argentina C1121ABG, and.ORCID 0000-0002-1453-3372
Adrián Rodríguez-ContrerasDepartment of Biology, City College of New York, New York, NY 10031.ORCID 0000-0002-2054-334X
Carolina WedemeyerInstituto de Investigaciones en Ingeniería Genética y Biología Molecular, Dr. Héctor N. Torres, INGEBI-CONICET, Buenos Aires, Argentina C1428ADN.ORCID 0000-0003-1757-5778
María Eugenia Gómez-CasatiInstituto de Farmacología, Facultad de Medicina, UBA, Buenos Aires, Argentina C1121ABG, and.ORCID 0000-0003-4923-8274
Ana Belén ElgoyhenInstituto de Investigaciones en Ingeniería Genética y Biología Molecular, Dr. Héctor N. Torres, INGEBI-CONICET, Buenos Aires, Argentina C1428ADN, elgoyhen@dna.uba.ar abelgoyhen@gmail.com mndiguilmi@dna.uba.ar.ORCID 0000-0001-9487-0311
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de Buenos Aires · ARCity College of New York · US

Funding

THE CHOLINERGIC RESPONSE OF COCHLEAR HAIR CELLSR01DC001508 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI Amanda M. Lauer · 1992 to 2026
$13.2M
Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
Neuronal ensembles during development of tonotopic maps in the auditory systemSC1DC015907 · NIDCD · CITY COLLEGE OF NEW YORK · PI RODRIGUEZ-CONTRERAS, ADRIAN · 2016 to 2018
$706k
NIDCD NIH HHS R01 DC001508NIDCD NIH HHS SC1 DC015907NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

The auditory system in many mammals is immature at birth but precisely organized in adults. Spontaneous activity in the inner ear plays a critical role in guiding this maturation process. This is shaped by an efferent pathway that descends from the brainstem and makes transient direct synaptic contacts with inner hair cells. In this work, we used an α9 cholinergic nicotinic receptor knock-in mouse model (of either sex) with enhanced medial efferent activity (

Indexed as

Evoked Potentials, Auditory, Brain StemSynaptic PotentialsAnimalsAuditory PerceptionCochleaFemaleHair Cells, AuditoryMaleMiceMotor NeuronsOlivary NucleusReceptors, NicotinicTrapezoid BodyChrna9 protein, mouseReceptors, NicotinicChrna9L9′Tefferent MOC inhibitionMNTBtonotopyα9α10 nAChR

Identifiers

PMID31217330
PMCPMC6733545
OpenAlexW2951529134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.